Print Friendly Page

Protocol No. UW16139

Principal Investigator Callander, Natalie

Phase N/A

Age Group Adult

Scope Local

Sponsor Type Industry

Title A Pilot Study to Evaluate the Therapeutic Response of Tumor Cells Co-cultured with Non-tumor Cells from Patients with Multiple Myeloma ex vivo

Objective Researchers at the University of Wisconsin in cooperation with Lynx Biosciences would like to collect an extra sample of your bone marrow (about 1-2 teaspoons) for research testing to help study the development, progression, and treatment of multiple myeloma.

Treatment In this study, you will have an extra sample of bone marrow collected for research at one time point. The extra research sample will be drawn at the time that you are having your regular bone marrow biopsy. Your sample will be used for studies to help investigate multiple myeloma and its treatment.

Description There are no other study-related procedures after the collection of the bone marrow sample. Often, patients have more than one bone marrow biopsy during the course of their clinical care. If you are scheduled for another clinical bone marrow biopsy, it is possible that you will be invited to participate in this study again at that time. You can choose to only participate one time, or you can give a research sample at every clinical biopsy. If you are invited to participate again, you would sign a new consent form at that time.

Key Eligibility
  • Presumed or confirmed diagnosis of multiple myeloma, including those with relapsed, refractory, or newly diagnosed disease
  • Planning to start chemotherapy within the next 6 weeks
  • Willingness to undergo bone marrow aspirate biopsy prior to initiation of next therapy
  • Subject is 18 years of age or older
  • Patients who are known to be HIV positive or Hepatitis B or C positive are excluded

Applicable Disease Sites Multiple Myeloma

Status Open

Participating Institutions UW Hospital and Clinics